Bastide Le Confort Medical annual ebitda
2021
2022
2023
2024
2025
Bastide Le Confort Medical's calculated EBITDA was €98.2M for fiscal 2025.
View full Bastide Le Confort Medical company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | €98.2M | €8.5M | +9.47% |
| 2024 | 2024-06-30 | €89.7M | −€5.7M | −6.02% |
| 2023 | 2023-06-30 | €95.5M | €6.9M | +7.74% |
| 2022 | 2022-06-30 | €88.6M | €9.5M | +12.00% |
| 2021 | 2021-06-30 | €79.1M | — | — |
Between the periods ended 2021-06-30 and 2025-06-30, Bastide Le Confort Medical's ebitda increased from €79.1M to €98.2M, a change of €19.1M.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bastide Le Confort Medical source filings ↗